Skip to main content
Equibles

MARTINGALE ASSET MANAGEMENT L P

Position in ZYME — Zymeworks Inc.

CIK 936944 BOSTON, MA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,915,591
+$1,095,181 QoQ
Shares Held
73,282
+123.7% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#69
of 203 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 68% Shared 0% None 32%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. ZYME ranks #21 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,729 $21,224,776
2 INCY
Incyte Corp
 168,818 $19,137,208
3 JAZZ
Jazz Pharmaceuticals plc
 59,492 $14,335,787
4 REGN
Regeneron Pharmaceuticals, Inc.
 18,953 $11,817,953
5 LGND
Ligand Pharmaceuticals Inc
 17,562 $5,551,172
6 ACAD
Acadia Pharmaceuticals Inc
 167,893 $4,247,692
7 ALNY
Alnylam Pharmaceuticals, Inc.
 13,634 $4,104,243
8 INVA
Innoviva, Inc.
 165,115 $3,749,761

All Filings in ZYME

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,915,591 73,282
2026-03-31 $820,410 32,764